Article

Optimizing Antiviral Therapy for COVID-19 With Learned Pathogenic Model

2021-09-21

Abstract excerpt

COVID-19 together with variants have caused an unprecedented amount of mental and economic turmoil with ever increasing fatality and no proven therapies in sight. The healthcare industry is racing to find a cure with multitude of clinical trials underway to access the efficacy of repurposed antivirals, however the much needed insights into the dynamics of pathogenesis of SARS-CoV-2 and corresponding pharmacology o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6c8c92b1-6dd8-5c09-8532-5cf3e39511dd
DOI: 10.21203/rs.3.rs-884630/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimizing Antiviral Therapy for COVID-19 With Learned Pathogenic ModelDOI 10.21203/rs.3.rs-884630/v1Read

Rapid Identification of Druggable Targets and the Power of the Phenotype SIMulator for Effective Drug Repurposing in COVID-19Semantic proximity Read

In silico dynamics of COVID-19 phenotypes for optimizing clinical managementSemantic proximity Read

In silico dynamics of COVID-19 phenotypes for optimizing clinical management.Semantic proximity Read

A Quantitative Systems Pharmacology Model of the Pathophysiology and Treatment of COVID-19 Predicts Optimal Timing of Pharmacological InterventionsSemantic proximity Read

A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.Semantic proximity Read

COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomesSemantic proximity Read

Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19Semantic proximity Read

The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy RegimensSemantic proximity Read

A Hybrid AI-driven Algorithm to Uncover Potential Therapeutic Targets for COVID-19 Using Network-based Drug RepurposingSemantic proximity Read

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory responseSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

DeepNEU: a machine learning platform for simulating Cytokine Storm and Coagulopathy that complicate severe COVID-19 to enable targeted drug repurposingSemantic proximity Read